ESC 365 - Applicability of VICTORION-1 PREVENT Criteria to the US Population

ESC Professional Premium Access

Applicability of VICTORION-1 PREVENT Criteria to the US Population

Session: Epidemiology of cardiovascular risk and disease

Topic: Epidemiology

Speaker: Doctor R. Aggarwal (Boston, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Rahul Aggarwal

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

0 follower

5 more presentations in this session

Cardiovascular disease burden and risk factor management in cancer survivors: insights from a large-scale East London cohort

Speaker: Doctor L. Szabo (Budapest, HU)

Heterogeneous associations of traditional atherosclerotic risk factors and long-term events in different arterial territories: the EPIC Norfolk prospective population cohort

Speaker: Miss M. van den Bogaart (Amsterdam, NL)

LDL-cholesterol and CRP as predictors of CV morbidity and mortality - a comprehensive analysis of data from the UK Biobank

Independent and joint associations of urinary potassium excretion with cardiovascular death: a national population-based cohort study

Speaker: Ms C. Lin (Beijing, CN)

The projected global burden of modifiable risk factors on cardiovascular disease from 2025 to 2100

Speaker: Mr B. Chong (Singapore, SG)

Access the full session

Epidemiology of cardiovascular risk and disease

Speakers: Doctor R. Aggarwal, Doctor L. Szabo, Miss M. van den Bogaart, Ms C. Lin, Mr B. Chong

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources